TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Minimally Invasive Treatment of Lung Cancer Market Research Report 2023

Global Minimally Invasive Treatment of Lung Cancer Market Research Report 2023

  • Category:Life Sciences
  • Published on : 15 December 2022
  • Pages :93
  • Formats:
  • Report Code:SMR-7511090
OfferClick for best price

Best Price: $2320

Minimally Invasive Treatment of Lung Cancer Market Size, Share 2022


Market Analysis and Insights: Global Minimally Invasive Treatment of Lung Cancer Market

The global Minimally Invasive Treatment of Lung Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Minimally Invasive Treatment of Lung Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Minimally Invasive Treatment of Lung Cancer market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Minimally Invasive Treatment of Lung Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Minimally Invasive Treatment of Lung Cancer market.

Global Minimally Invasive Treatment of Lung Cancer Scope and Market Size

Market Analysis and Insights: Global Minimally Invasive Treatment of Lung Cancer Market

The minimally invasive treatment method for lung cancer is to cut relatively small wounds around the lung, and then perform local resection through thoracoscopy. The skin injury is relatively small during the operation, and the recovery period after the operation will be very short.

The global Minimally Invasive Treatment of Lung Cancer market size is projected to reach US$ million by 2030, from US$ million in 2022, at a CAGR of % during 2023-2030.

Fully considering the economic change by this health crisis, Lung Tumor Ablation accounting for % of the Minimally Invasive Treatment of Lung Cancer global market in 2022, is projected to value US$ million by 2030, growing at a revised % CAGR from 2023 to 2030. While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Minimally Invasive Treatment of Lung Cancer market size is valued at US$ million in 2022, while the North America and Europe Minimally Invasive Treatment of Lung Cancer are US$ million and US$ million, severally. The proportion of the North America is % in 2022, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2030, trailing a CAGR of % through the analysis period 2023-2030. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Minimally Invasive Treatment of Lung Cancer landscape, Germany is projected to reach US$ million by 2030 trailing a CAGR of % over the forecast period 2023-2030.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Minimally Invasive Treatment of Lung Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Minimally Invasive Treatment of Lung Cancer market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Minimally Invasive Treatment of Lung Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Minimally Invasive Treatment of Lung Cancer market.

Global Minimally Invasive Treatment of Lung Cancer Scope and Market Size

Minimally Invasive Treatment of Lung Cancer market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Minimally Invasive Treatment of Lung Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2030.

Segment by Type

Lung Tumor Ablation

Lung Tumor Embolization

Segment by Application

Hospitals

Ambulatory Surgical Centers

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Medtronic

Olympus

LungCare

Broncus

Intuitive Surgica

Auris Health

Angiodynamics

Boston Scientific

Smith and Nephew

VISON Medical

Nanjing MICRO-TECH

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Minimally Invasive Treatment of Lung Cancer product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Minimally Invasive Treatment of Lung Cancer, with price, sales, revenue, and global market share of Minimally Invasive Treatment of Lung Cancer from 2019 to 2022.

Chapter 3, the Minimally Invasive Treatment of Lung Cancer competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Minimally Invasive Treatment of Lung Cancer breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Minimally Invasive Treatment of Lung Cancer market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Minimally Invasive Treatment of Lung Cancer.

Chapter 13, 14, and 15, to describe Minimally Invasive Treatment of Lung Cancer sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Minimally Invasive Treatment of Lung Cancer Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Minimally Invasive Treatment of Lung Cancer Market Research Report 2023
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 93 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Lung Tumor Ablation
1.2.3 Lung Tumor Embolization
1.3 Market by Application
1.3.1 Global Minimally Invasive Treatment of Lung Cancer Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Minimally Invasive Treatment of Lung Cancer Market Perspective (2018-2030)
2.2 Minimally Invasive Treatment of Lung Cancer Growth Trends by Region
2.2.1 Minimally Invasive Treatment of Lung Cancer Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Minimally Invasive Treatment of Lung Cancer Historic Market Size by Region (2018-2023)
2.2.3 Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Region (2023-2030)
2.3 Minimally Invasive Treatment of Lung Cancer Market Dynamics
2.3.1 Minimally Invasive Treatment of Lung Cancer Industry Trends
2.3.2 Minimally Invasive Treatment of Lung Cancer Market Drivers
2.3.3 Minimally Invasive Treatment of Lung Cancer Market Challenges
2.3.4 Minimally Invasive Treatment of Lung Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Minimally Invasive Treatment of Lung Cancer Players by Revenue
3.1.1 Global Top Minimally Invasive Treatment of Lung Cancer Players by Revenue (2018-2023)
3.1.2 Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Players (2018-2023)
3.2 Global Minimally Invasive Treatment of Lung Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Minimally Invasive Treatment of Lung Cancer Revenue
3.4 Global Minimally Invasive Treatment of Lung Cancer Market Concentration Ratio
3.4.1 Global Minimally Invasive Treatment of Lung Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Minimally Invasive Treatment of Lung Cancer Revenue in 2022
3.5 Minimally Invasive Treatment of Lung Cancer Key Players Head office and Area Served
3.6 Key Players Minimally Invasive Treatment of Lung Cancer Product Solution and Service
3.7 Date of Enter into Minimally Invasive Treatment of Lung Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Minimally Invasive Treatment of Lung Cancer Breakdown Data by Type
4.1 Global Minimally Invasive Treatment of Lung Cancer Historic Market Size by Type (2018-2023)
4.2 Global Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Type (2023-2030)
5 Minimally Invasive Treatment of Lung Cancer Breakdown Data by Application
5.1 Global Minimally Invasive Treatment of Lung Cancer Historic Market Size by Application (2018-2023)
5.2 Global Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Minimally Invasive Treatment of Lung Cancer Market Size (2018-2030)
6.2 North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2018-2023)
6.3 North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Minimally Invasive Treatment of Lung Cancer Market Size (2018-2030)
7.2 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2018-2023)
7.3 Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size (2018-2030)
8.2 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size by Country (2018-2023)
8.3 Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Minimally Invasive Treatment of Lung Cancer Market Size (2018-2030)
9.2 Latin America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2018-2023)
9.3 Latin America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size (2018-2030)
10.2 Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2018-2023)
10.3 Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Minimally Invasive Treatment of Lung Cancer Introduction
11.1.4 Medtronic Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
11.1.5 Medtronic Recent Development
11.2 Olympus
11.2.1 Olympus Company Detail
11.2.2 Olympus Business Overview
11.2.3 Olympus Minimally Invasive Treatment of Lung Cancer Introduction
11.2.4 Olympus Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
11.2.5 Olympus Recent Development
11.3 LungCare
11.3.1 LungCare Company Detail
11.3.2 LungCare Business Overview
11.3.3 LungCare Minimally Invasive Treatment of Lung Cancer Introduction
11.3.4 LungCare Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
11.3.5 LungCare Recent Development
11.4 Broncus
11.4.1 Broncus Company Detail
11.4.2 Broncus Business Overview
11.4.3 Broncus Minimally Invasive Treatment of Lung Cancer Introduction
11.4.4 Broncus Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
11.4.5 Broncus Recent Development
11.5 Intuitive Surgica
11.5.1 Intuitive Surgica Company Detail
11.5.2 Intuitive Surgica Business Overview
11.5.3 Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Introduction
11.5.4 Intuitive Surgica Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
11.5.5 Intuitive Surgica Recent Development
11.6 Auris Health
11.6.1 Auris Health Company Detail
11.6.2 Auris Health Business Overview
11.6.3 Auris Health Minimally Invasive Treatment of Lung Cancer Introduction
11.6.4 Auris Health Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
11.6.5 Auris Health Recent Development
11.7 Angiodynamics
11.7.1 Angiodynamics Company Detail
11.7.2 Angiodynamics Business Overview
11.7.3 Angiodynamics Minimally Invasive Treatment of Lung Cancer Introduction
11.7.4 Angiodynamics Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
11.7.5 Angiodynamics Recent Development
11.8 Boston Scientific
11.8.1 Boston Scientific Company Detail
11.8.2 Boston Scientific Business Overview
11.8.3 Boston Scientific Minimally Invasive Treatment of Lung Cancer Introduction
11.8.4 Boston Scientific Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
11.8.5 Boston Scientific Recent Development
11.9 Smith and Nephew
11.9.1 Smith and Nephew Company Detail
11.9.2 Smith and Nephew Business Overview
11.9.3 Smith and Nephew Minimally Invasive Treatment of Lung Cancer Introduction
11.9.4 Smith and Nephew Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
11.9.5 Smith and Nephew Recent Development
11.10 VISON Medical
11.10.1 VISON Medical Company Detail
11.10.2 VISON Medical Business Overview
11.10.3 VISON Medical Minimally Invasive Treatment of Lung Cancer Introduction
11.10.4 VISON Medical Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
11.10.5 VISON Medical Recent Development
11.11 Nanjing MICRO-TECH
11.11.1 Nanjing MICRO-TECH Company Detail
11.11.2 Nanjing MICRO-TECH Business Overview
11.11.3 Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Introduction
11.11.4 Nanjing MICRO-TECH Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
11.11.5 Nanjing MICRO-TECH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Minimally Invasive Treatment of Lung Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2030
Table 2. Key Players of Lung Tumor Ablation
Table 3. Key Players of Lung Tumor Embolization
Table 4. Global Minimally Invasive Treatment of Lung Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2030
Table 5. Global Minimally Invasive Treatment of Lung Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2030
Table 6. Global Minimally Invasive Treatment of Lung Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Minimally Invasive Treatment of Lung Cancer Market Share by Region (2018-2023)
Table 8. Global Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 9. Global Minimally Invasive Treatment of Lung Cancer Market Share by Region (2023-2030)
Table 10. Minimally Invasive Treatment of Lung Cancer Market Trends
Table 11. Minimally Invasive Treatment of Lung Cancer Market Drivers
Table 12. Minimally Invasive Treatment of Lung Cancer Market Challenges
Table 13. Minimally Invasive Treatment of Lung Cancer Market Restraints
Table 14. Global Minimally Invasive Treatment of Lung Cancer Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Minimally Invasive Treatment of Lung Cancer Market Share by Players (2018-2023)
Table 16. Global Top Minimally Invasive Treatment of Lung Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimally Invasive Treatment of Lung Cancer as of 2022)
Table 17. Ranking of Global Top Minimally Invasive Treatment of Lung Cancer Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Minimally Invasive Treatment of Lung Cancer Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Minimally Invasive Treatment of Lung Cancer Product Solution and Service
Table 21. Date of Enter into Minimally Invasive Treatment of Lung Cancer Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Minimally Invasive Treatment of Lung Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Type (2018-2023)
Table 25. Global Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 26. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Type (2023-2030)
Table 27. Global Minimally Invasive Treatment of Lung Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Application (2018-2023)
Table 29. Global Minimally Invasive Treatment of Lung Cancer Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 30. Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share by Application (2023-2030)
Table 31. North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2023-2030) & (US$ Million)
Table 33. Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 34. Europe Minimally Invasive Treatment of Lung Cancer Market Size by Country (2023-2030) & (US$ Million)
Table 35. Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 36. Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size by Region (2023-2030) & (US$ Million)
Table 37. Latin America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 38. Latin America Minimally Invasive Treatment of Lung Cancer Market Size by Country (2023-2030) & (US$ Million)
Table 39. Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 40. Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size by Country (2023-2030) & (US$ Million)
Table 41. Medtronic Company Detail
Table 42. Medtronic Business Overview
Table 43. Medtronic Minimally Invasive Treatment of Lung Cancer Product
Table 44. Medtronic Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023) & (US$ Million)
Table 45. Medtronic Recent Development
Table 46. Olympus Company Detail
Table 47. Olympus Business Overview
Table 48. Olympus Minimally Invasive Treatment of Lung Cancer Product
Table 49. Olympus Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023) & (US$ Million)
Table 50. Olympus Recent Development
Table 51. LungCare Company Detail
Table 52. LungCare Business Overview
Table 53. LungCare Minimally Invasive Treatment of Lung Cancer Product
Table 54. LungCare Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023) & (US$ Million)
Table 55. LungCare Recent Development
Table 56. Broncus Company Detail
Table 57. Broncus Business Overview
Table 58. Broncus Minimally Invasive Treatment of Lung Cancer Product
Table 59. Broncus Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023) & (US$ Million)
Table 60. Broncus Recent Development
Table 61. Intuitive Surgica Company Detail
Table 62. Intuitive Surgica Business Overview
Table 63. Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Product
Table 64. Intuitive Surgica Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023) & (US$ Million)
Table 65. Intuitive Surgica Recent Development
Table 66. Auris Health Company Detail
Table 67. Auris Health Business Overview
Table 68. Auris Health Minimally Invasive Treatment of Lung Cancer Product
Table 69. Auris Health Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023) & (US$ Million)
Table 70. Auris Health Recent Development
Table 71. Angiodynamics Company Detail
Table 72. Angiodynamics Business Overview
Table 73. Angiodynamics Minimally Invasive Treatment of Lung Cancer Product
Table 74. Angiodynamics Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023) & (US$ Million)
Table 75. Angiodynamics Recent Development
Table 76. Boston Scientific Company Detail
Table 77. Boston Scientific Business Overview
Table 78. Boston Scientific Minimally Invasive Treatment of Lung Cancer Product
Table 79. Boston Scientific Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023) & (US$ Million)
Table 80. Boston Scientific Recent Development
Table 81. Smith and Nephew Company Detail
Table 82. Smith and Nephew Business Overview
Table 83. Smith and Nephew Minimally Invasive Treatment of Lung Cancer Product
Table 84. Smith and Nephew Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023) & (US$ Million)
Table 85. Smith and Nephew Recent Development
Table 86. VISON Medical Company Detail
Table 87. VISON Medical Business Overview
Table 88. VISON Medical Minimally Invasive Treatment of Lung Cancer Product
Table 89. VISON Medical Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023) & (US$ Million)
Table 90. VISON Medical Recent Development
Table 91. Nanjing MICRO-TECH Company Detail
Table 92. Nanjing MICRO-TECH Business Overview
Table 93. Nanjing MICRO-TECH Minimally Invasive Treatment of Lung CancerProduct
Table 94. Nanjing MICRO-TECH Revenue in Minimally Invasive Treatment of Lung Cancer Business (2018-2023) & (US$ Million)
Table 95. Nanjing MICRO-TECH Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Minimally Invasive Treatment of Lung Cancer Market Share by Type: 2022 VS 2030
Figure 2. Lung Tumor Ablation Features
Figure 3. Lung Tumor Embolization Features
Figure 4. Global Minimally Invasive Treatment of Lung Cancer Market Share by Application in 2022 & 2030
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Minimally Invasive Treatment of Lung Cancer Report Years Considered
Figure 8. Global Minimally Invasive Treatment of Lung Cancer Market Size (US$ Million), Year-over-Year: 2018-2030
Figure 9. Global Minimally Invasive Treatment of Lung Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2030
Figure 10. Global Minimally Invasive Treatment of Lung Cancer Market Share by Region: 2022 VS 2030
Figure 11. Global Minimally Invasive Treatment of Lung Cancer Market Share by Players in 2022
Figure 12. Global Top Minimally Invasive Treatment of Lung Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimally Invasive Treatment of Lung Cancer as of 2022)
Figure 13. The Top 10 and 5 Players Market Share by Minimally Invasive Treatment of Lung Cancer Revenue in 2022
Figure 14. North America Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 15. North America Minimally Invasive Treatment of Lung Cancer Market Share by Country (2018-2030)
Figure 16. United States Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 17. Canada Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 18. Europe Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 19. Europe Minimally Invasive Treatment of Lung Cancer Market Share by Country (2018-2030)
Figure 20. Germany Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 21. France Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 22. U.K. Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 23. Italy Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 24. Russia Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 25. Nordic Countries Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 26. Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 27. Asia-Pacific Minimally Invasive Treatment of Lung Cancer Market Share by Region (2018-2030)
Figure 28. China Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 29. Japan Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 30. South Korea Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 31. Southeast Asia Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 32. India Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 33. Australia Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 34. Latin America Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 35. Latin America Minimally Invasive Treatment of Lung Cancer Market Share by Country (2018-2030)
Figure 36. Mexico Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 37. Brazil Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 38. Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 39. Middle East & Africa Minimally Invasive Treatment of Lung Cancer Market Share by Country (2018-2030)
Figure 40. Turkey Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 41. Saudi Arabia Minimally Invasive Treatment of Lung Cancer Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 42. Medtronic Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
Figure 43. Olympus Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
Figure 44. LungCare Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
Figure 45. Broncus Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
Figure 46. Intuitive Surgica Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
Figure 47. Auris Health Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
Figure 48. Angiodynamics Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
Figure 49. Boston Scientific Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
Figure 50. Smith and Nephew Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
Figure 51. VISON Medical Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
Figure 52. Nanjing MICRO-TECH Revenue Growth Rate in Minimally Invasive Treatment of Lung Cancer Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount